Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson’s disease

Neurobiology of Disease

Volumn 8, Issue 4, 2001, Pages 707-716

  Anichtchik, Oleg V ^a,b   Peitsaro, Nina ^a   Rinne, J O ^b   Kalimo, Hannu ^c,d   Panula, P ^e  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GUANOSINE TRIPHOSPHATE; HISTAMINE; HISTAMINE H3 RECEPTOR; N METHYLHISTAMINE;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BINDING SITE; CLINICAL ARTICLE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIGAND BINDING; MALE; OLIGONUCLEOTIDE PROBE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BINDING; RECEPTOR DENSITY; SUBSTANTIA NIGRA;

EID: 0034879048     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0413     Document Type: Article

References (55)

1. Histamine neurons in human hypothalamus: Anatomy in normal and Alzheimer diseased brains
2. Modulation of histamine H3 receptors in the brain of unilaterally 6-hydroxydopamine lesioned rats
3. An altered histaminergic innervation of the substantia nigra in Parkinson’s disease
4. H3-receptors control histamine release in human brain
5. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
6. Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors
7. Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats
8. Pathoanatomy of Parkinson’s disease
9. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia
10. The distribution of histidine decarboxylase mRNA in the rat brain: An in situ hybridization study using synthetic oligonucleotide probes
11. Histamine and spontaneous motor activity: Biphasic changes, receptors involved and participation of the striatal dopamine system
12. Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
13. 3 receptor subtypes with different brain expression and signaling properties
14. Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata
15. Distribution of histamine H3-receptor binding in the normal human basal ganglia: Comparison with Huntington’s and Parkinson’s disease cases
16. Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: Effects of post mortem interval, subject age, and Alzheimer’s disease
17. Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: Effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine and levodopa treatment
18. International Union of Pharmacology. XIII. Classification of histamine receptors
19. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: A clinicopathological study
20. Lack of histamine synthesis and down-regulation of H1 and H2 receptor mRNA levels by dexamethasone in cerebral endothelial cells
21. Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson’s disease: Correlation with striatal dopamine loss
22. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
23. Guanosine 5′-(gamma-[35S]thio) triphosphate autoradiography allows selective detection of histamine H3 receptor-dependent G protein activation in rat brain tissue sections
24. MPTP: Insights into the etiology of Parkinson’s disease
25. Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: Antagonist studies
26. Zolpidem binding sites on the GABA(A) receptor in brain from human cirrhotic and non-cirrhotic alcoholics
27. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat
28. L-glutamic acid decarboxylase in Parkinson’s disease: Effect of L-dopa therapy
29. Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and parkinsonian patients
30. Cloning and functional expression of the human histamine H3 receptor
31. Loss of striatal histamine H2 receptors in Huntington’s chorea but not in Parkinson’s disease: Comparison with animal models
32. A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol
33. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders
34. A histamine-containing neuronal system in human brain
35. The histaminergic system in the brain: Structural characteristics and changes in hibernation
36. Neuronal histamine deficit in Alzheimer’s disease
37. Histamine-containing nerve fibers innervate human cerebellum
38. Identification of a histamine H (3)-like receptor in the zebrafish (Danio rerio) brain
39. Mapping of a gene for Parkinson’s disease to chromosome 4q21-q23
40. Brain enkephalin receptors in Parkinson’s disease
41. Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: An autoradiographic study
42. The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones
43. Effects of (S)-alpha-fluoromethylhistidine and (R)-alpha-methylhistamine on locomotion of W/Wv mice
44. Major changes in the brain histamine system of the ground squirrel Citellus lateralis during hibernation
45. Reduction of cortical dopamine, noradrenaline, serotonine and their metabolites in Parkinson’s disease
46. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding
47. Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex
48. Modulation of neurotransmitter release via histamine H3 hetero-receptors
49. Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain
50. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding
51. 5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5′-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography
52. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson’s disease and Huntington’s chorea
53. The profiles of human and primate [3H]-N-alpha-methylhistamine binding differ from that of rodents
54. Functional and pathophysiological models of the basal ganglia